Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1826 2
1827 1
2010 1
2015 1
2018 2
2019 1
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Transmission of Mycobacterium tuberculosis to Healthcare Personnel Resulting From Contaminated Bone Graft Material, United States, June 2021-August 2022.
Li R, Deutsch-Feldman M, Adams T, Law M, Biak C, Pitcher E, Drees M, Hernandez-Romieu AC, Filardo TD, Cropper T, Martinez A, Wyatt Wilson W, Althomsons SP, Morris SB, Wortham JM, Benowitz I, Schwartz NG, White K, Haddad MB, Glowicz JB; Bone Allograft Tuberculosis Investigators. Li R, et al. Clin Infect Dis. 2023 May 24;76(10):1847-1849. doi: 10.1093/cid/ciad029. Clin Infect Dis. 2023. PMID: 36660866
Clinical Impact of High Throughput Sequencing on Liquid Biopsy in Advanced Solid Cancer.
Gouton E, Malissen N, André N, Jeanson A, Pelletier A, Testot-Ferry A, Gaudy-Marqueste C, Dahan L, Tabouret E, Chevalier T, Greillier L, Tomasini P. Gouton E, et al. Among authors: chevalier t. Curr Oncol. 2022 Mar 10;29(3):1902-1918. doi: 10.3390/curroncol29030155. Curr Oncol. 2022. PMID: 35323355 Free PMC article.
Prognostic Value of the B12/CRP Index in Older Systemically Treatable Cancer Patients.
Montegut C, Correard F, Nouguerède E, Rey D, Chevalier T, Meurer M, Deville JL, Baciuchka M, Pradel V, Greillier L, Villani P, Couderc AL. Montegut C, et al. Among authors: chevalier t. Cancers (Basel). 2021 Dec 30;14(1):169. doi: 10.3390/cancers14010169. Cancers (Basel). 2021. PMID: 35008333 Free PMC article.
Efficacy of second-line chemotherapy or immune checkpoint inhibitors for patients with a prolonged objective response (≥ 6 months) after first-line therapy for recurrent or metastatic head and neck squamous cell carcinoma: a retrospective study.
Vienne A, Collet L, Chevalier T, Borel C, Tardy M, Huguet F, Richard S, Salas S, Saada-Bouzid E, Fayette J, Daste A. Vienne A, et al. Among authors: chevalier t. BMC Cancer. 2023 Jul 14;23(1):663. doi: 10.1186/s12885-023-11133-5. BMC Cancer. 2023. PMID: 37452287 Free PMC article.
Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME.
Chevalier T, Daste A, Saada-Bouzid E, Loundou A, Peyraud F, Lambert T, Le Tourneau C, Peyrade F, Dupuis C, Alfonsi M, Fayette J, Reure J, Huguet F, Fakhry N, Toullec C, Salas S. Chevalier T, et al. Cancer Med. 2021 Jun;10(12):3952-3963. doi: 10.1002/cam4.3953. Epub 2021 May 25. Cancer Med. 2021. PMID: 34080776 Free PMC article.
Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study.
Callejo A, Faouzi S, Bouché O, Bertucci F, Chevalier T, Isambert N, Duffaud F, Collard O, Penel N, Terrier P, Mir O, Blay JY, Le Cesne A. Callejo A, et al. Among authors: chevalier t. Target Oncol. 2021 Jul;16(4):485-492. doi: 10.1007/s11523-021-00820-7. Epub 2021 Jun 5. Target Oncol. 2021. PMID: 34089444
13 results